Serum uric acid in normal and hypertensive Australian subjects.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001315:Australia; D002648:Child; D003124:Colorimetry; D003647:Debrisoquin / Q000627:therapeutic use; D005260:Female; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications; D006973:Hypertension / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D006977:Hypertension, Renal / Q000097:blood; D007676:Kidney Failure, Chronic / Q000097:blood; D008297:Male; D008659:Metabolic Diseases / Q000150:complications; D008750:Methyldopa / Q000627:therapeutic use; D008875:Middle Aged; D013565:Sympatholytics / Q000627:therapeutic use; D014527:Uric Acid / Q000097:blood*
D013565:Sympatholytics; D014527:Uric Acid; D008750:Methyldopa; D003647:Debrisoquin; D006145:Guanethidine